BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27544803)

  • 21. Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.
    Li Z; Jia M; Wu X; Cui J; Pan A; Li L
    Diagn Pathol; 2015 Sep; 10():167. PubMed ID: 26377811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.
    Bielack SS; Kempf-Bielack B; Delling G; Exner GU; Flege S; Helmke K; Kotz R; Salzer-Kuntschik M; Werner M; Winkelmann W; Zoubek A; Jürgens H; Winkler K
    J Clin Oncol; 2002 Feb; 20(3):776-90. PubMed ID: 11821461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
    Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
    Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy.
    Min D; Lin F; Shen Z; Zheng S; Tan L; Yu W; Yao Y
    Asia Pac J Clin Oncol; 2013 Mar; 9(1):71-9. PubMed ID: 22897971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients.
    Nataraj V; Rastogi S; Khan SA; Sharma MC; Agarwala S; Vishnubhatla S; Bakhshi S
    Clin Transl Oncol; 2016 Sep; 18(9):937-44. PubMed ID: 26742936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma.
    Kim MS; Lee SY; Lee TR; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    Ann Oncol; 2009 May; 20(5):955-60. PubMed ID: 19153123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of serum lactate dehydrogenase in osteosarcoma of the extremity: experience at Rizzoli on 1421 patients treated over the last 30 years.
    Bacci G; Longhi A; Ferrari S; Briccoli A; Donati D; De Paolis M; Versari M
    Tumori; 2004; 90(5):478-84. PubMed ID: 15656333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution Experience.
    Berlanga P; Cañete A; Díaz R; Salom M; Baixauli F; Gómez J; Llavador M; Castel V
    J Pediatr Hematol Oncol; 2015 Jul; 37(5):e272-7. PubMed ID: 25374283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
    Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
    Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
    Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
    PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age and Tumor Location Predict Survival in Nonmetastatic Osteosarcoma in Upper Egypt.
    Morsy AM; Ahmed BM; Rezk KM; Ramadan IK; Aboelgheit AM; Eltyb HA; Abd Elbadee OM; El-Naggar MS
    J Pediatr Hematol Oncol; 2020 Mar; 42(2):e66-e78. PubMed ID: 31107367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can pretreatment
    Song H; Jiao Y; Wei W; Ren X; Shen C; Qiu Z; Yang Q; Wang Q; Luo QY
    Eur Radiol; 2019 Jul; 29(7):3945-3954. PubMed ID: 30859285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma.
    Dumars C; Ngyuen JM; Gaultier A; Lanel R; Corradini N; Gouin F; Heymann D; Heymann MF
    Oncotarget; 2016 Nov; 7(48):78343-78354. PubMed ID: 27823976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The β5/focal adhesion kinase/glycogen synthase kinase 3β integrin pathway in high-grade osteosarcoma: a protein expression profile predictive of response to neoadjuvant chemotherapy.
    Le Guellec S; Moyal EC; Filleron T; Delisle MB; Chevreau C; Rubie H; Castex MP; de Gauzy JS; Bonnevialle P; Gomez-Brouchet A
    Hum Pathol; 2013 Oct; 44(10):2149-58. PubMed ID: 23845472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
    Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
    Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What are the factors that affect survival and relapse after local recurrence of osteosarcoma?
    Takeuchi A; Lewis VO; Satcher RL; Moon BS; Lin PP
    Clin Orthop Relat Res; 2014 Oct; 472(10):3188-95. PubMed ID: 24980644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities.
    Serra M; Scotlandi K; Reverter-Branchat G; Ferrari S; Manara MC; Benini S; Incaprera M; Bertoni F; Mercuri M; Briccoli A; Bacci G; Picci P
    J Clin Oncol; 2003 Feb; 21(3):536-42. PubMed ID: 12560446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reporting Surgical Resection Margin Status for Osteosarcoma: Comparison of the AJCC, MSTS, and Margin Distance Methods.
    Cates JM
    Am J Surg Pathol; 2017 May; 41(5):633-642. PubMed ID: 28125453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of p53 alterations in human osteosarcoma: a meta analysis.
    Yao D; Cai GH; Chen J; Ling R; Wu SX; Li YP
    Int J Clin Exp Pathol; 2014; 7(10):6725-33. PubMed ID: 25400752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.